Is HIFU Prostate Cancer Treatment for You?

Since many men are diagnosed with early-stage prostate cancer, often, they must choose between a risky surgical intervention, no treatment at all, or simply monitoring the disease. Among the many treatment options available HIFU falls somewhere in the middle.

HIFU, which stands for high intensity focused ultrasound, offers a less invasive, lower risk method of eliminating the prostate in the body with fewer complications. With HIFU physicians are able to target and treat small amounts of tissue, minimizing damage to nerves around the prostate responsible for preserving potency.

HIFU is an FDA approved precise and targeted therapy that reduces the risk of complications caused by surgery and radiation. HIFU uses ultrasound energy, or sound waves, to heat and destroy specifically targeted areas of tissue. During HIFU, the sound waves pass through healthy tissue without causing damage. At the focal point of the sound waves (like a magnifying glass focusing the rays of the sun to burn a leaf), the tissue temperature is raised to 90 degrees Celsius, destroying the targeted tissue. When HIFU is the best option

Men treated with HIFU wake up and go home without pain or bleeding.  They are able to travel the same day, drive the next day, and resume normal activities within a few days.  Those with office based jobs can go back to work the next day.  A catheter is left in for 5 days to 3 weeks, depending on how much of the gland is treated and/or the degree of swelling.

Focal Therapy is not associated with incontinence, and erectile dysfunction is just under 10%.  Sparing of the urethra avoids scar tissue formation which, when present, may diminish the urinary stream.  The eventual need for additional therapy is now under 10%.

Total Gland Therapy is necessary for men with significant cancer on both sides of the gland.  Incontinence of a few drops of urine (soaking pads is not seen) is limited to 2-3%.  Erectile dysfunction is only 10-20% as opposed to the much higher rates seen with surgery or radiation.  Scar tissue formation occurs in 10-20% of men who have the whole gland treated due to the involvement of the urethra.  We are developing techniques to treat the whole gland while sparing the urethra.  Cancer cure rates are comparable to surgery and radiation.

More about HIFU:

  • HIFU research began in the 1950s in Indianapolis, IN.
  • Over the years HIFU has evolved to the applications we have today which include treating various types of cancer and diseases, including prostate cancer.
  • Over 13,000 prostate patients have been treated with Sonablate HIFU.
  • There are more than 50 countries where HIFU has regulatory authorization.
  • In October 2015, Sonablate became the first device to receive regulatory authorization from the FDA for ablation of prostate tissue

Find out more about your treatment options

Sonablate® HIFU is most effective for men who have early stage, localized prostate cancer that has not spread or metastasized outside the prostate. However, it is recommended that you discuss your individual medical records and history with a physician in order to confirm whether or not you are a candidate for HIFU.

HIFU with the Sonablate® 500 has many proven advantages over traditional treatment modalities for prostate disease. To find out if you qualify please fill out the form below. HIFU may not be appropriate in every situation, but it is most effective for men who have early stage, localized prostate cancer that has not spread or metastasized outside the prostate.

Please make sure you provide a good description of your medical history including:

  • Recent PSA
  • Gleason Score
  • Prostate Size/Volume
  • Treatment strategy thus far
  • Any other relevant medical information

Dr. Michael Lazar now offers a HIFU Program in partnership with HIFU Prostate Services, LLC (HPS). HIFU Prostate Services, LLC (HPS) is a leading provider of minimally-invasive prostate cancer treatments using High Intensity Focused Ultrasound (HIFU). HIFU prostate treatments are performed at San Francisco Surgery Center (SFSC). SFSC offers patients a state-of-the-art facility that is convenient to hotels and the airport.

Call Dr. Lazar at (707) 546-5553 for more information and to learn if you qualify , or simply fill out and submit our questionnaire.